Pure Global AI
FDA product code PTA

Genetic Variant Detection And Health Risk Assessment System

ImmunologyClass 221 CFR 866.5950
US regulatory classifications
US Product Code (FDA)
PTA
US Risk Class (FDA)
Class 2
US Regulation (CFR)
21 CFR 866.5950
Medical specialty
Immunology
Device characteristics
GMP exempt
No
Implantable
No
Life-sustaining
No
Third party review
Not Eligible
Definition

A qualitative in vitro molecular test that detects variants in genomic DNA isolated from human specimens. This assessment system provides users with a genetic health risk assessment of developing a disease and is intended to inform users of lifestyle choices and/or encourage conversations with a healthcare professional. This assessment system is for over-the-counter use. This device does not determine the person’s overall risk of developing a disease.

Search keywords
About this record

Genetic Variant Detection And Health Risk Assessment System is a medical device type in the Immunology specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.